A new method of establishing orthotopic bladder transplantable tumor in mice

Cancer Biology and Medicine

Volumn 9, Issue 4, 2012, Pages 261-265

  Yang, Xi Hua ^a   Ren, Lian Sheng ^a   Wang, Guo Ping ^a   Zhao, Li Li ^a   Zhang, Hong ^b   Mi, Zhen Guo ^a   Bai, Xihua ^a  

^a SHANXI CANCER HOSPITAL   (China)

^b Shanxi Institute for Food and Drug Control   (China)

Author keywords

Bladder tumor; Mice; Model

Indexed keywords

PENTOBARBITAL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER MUCOSA; BLADDER TUMOR; CACHEXIA; CANCER GRAFT; CANCER INCIDENCE; CANCER SURVIVAL; CELL SUSPENSION; CONTROLLED STUDY; FEMALE; LUBRICATION; MARASMUS; MOUSE; NONHUMAN; SURVIVAL TIME;

EID: 84876317083     PISSN: 20953941     EISSN: None     Source Type: Journal    
DOI: 10.7497/j.issn.2095-3941.2012.04.007     Document Type: Article

References (14)

1. Chan E, Patel A, Heston W, et al. Mouse orthotopic models for bladder cancer research. BJU Int 2009; 104: 1286-1291.
2. Dinney CPN, Fishbeck R, Singh RK, et al. Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice. J Urol 1995; 154: 1532-1538.
3. Soloway MS. Intravesical and systemic chemotherapy of murine bladder cancer. Cancer Res 1977; 37: 2918-2929.
4. Xiao Z, McCallum TJ, Brown KM, et al. Characterization of a novel transplantable orthotopic rat bladder transitional cell tumour model. Br J Cancer 1999; 81: 638-646.
5. Chin J, Kadhim S, Garcia B, et al. Magnetic resonance imaging for detecting and treatment monitoring of orthotopic murine bladder tumor implants. J Urol 1991; 145: 1297-1301.
6. Jiang F, Zhou X-M. A model of orthotopic murine bladder (MBT-2) tumor implants. Urol Res 1997; 25: 179-182
7. Bachor R, Flotte TJ, Scholz M, et al. Comparison of intravenous and intravesical administration of chloro-aluminium sulfonated phthalocyanine for photodynamic treatment in a rat bladder cancer model. J Urol 1992; 147: 1404-1410.
8. Harney JV, Wahl RL, Liebert M, et al. Uptake of 2-deoxy, 2-(18F) fluoro-D-glucose in bladder cancer: Animal localization and initial patient positron emission tomography. J Urol 1991; 145: 279-283.
9. Ibrahiem EHI, Nigam VN, Brailovsky CA, et al. Orthotopic implantation of primary N-[4-(nitro-2-furyl) 2-thiazolyl] formamide-induced bladder cancer in bladder submucosa: An animal model for bladder cancer study. Cancer Res 1983; 43: 617-622
10. Bonney WW, Henstorf JE, Emaus SP, et al. Immunostimulation by cryosurgery: An orthotopic model of prostate and bladder cancer in the rat. Natl Cancer Inst Monogr 1978; 49: 375-381.
11. Oshinsky GS, Chen Y, Jarrett T. A model of bladder tumor xenografts in the nude rat. J Urol 1995; 154: 1925-1929.
12. Chade DC, Borra RC, Nascimento IP, et al. Immunomodulatory effects of recombinant BCG expressing pertussis toxin on TNFalpha and IL-10 in a bladder cancer model. J Exp Clin Cancer Res 2008; 27: 7-8.
13. Chan ES, Patel AR, Smith AK, et al. Optimizing orthotopic bladder tumor implantation in a syngeneic mouse model. J Urol 2009; 182: 2926-2931.
14. Bisson JF, Parache RM, Droulle P, et al. A new method of implanting orthotopic rat bladder tumor for experimental therapies. Int J Cancer 2002; 102: 280-285.